Doximity Scribe vs Medscape Scribe (2026)
The two free scribes distributed inside clinical media platforms that most United States physicians already use, which makes distribution rather than technology the whole story. Doximity covers every user under a business associate agreement regardless of price, stores no audio and names the processor, which is a stronger data position than many paid products manage. Medscape publishes a specific retention commitment with transcripts deleted after a short stated window and names its review step. Neither integrates with a record system, so in both cases the note comes back to the clinician and goes no further, which is the limitation that defines this tier. If you want a note without procurement, either works. If the note has to reach the chart, neither does, and that is the moment to look at the paid tier.
- Every user is covered by a business associate agreement regardless of paying nothing, which removes the question that gates most free clinical tools.
- No audio is stored or retained, recordings are processed in real time and discarded once the note is generated, and the processor is named.
- The distribution reaches a very large share of United States clinicians through an account most already have, so adoption requires no decision by anyone but the clinician.
- It publishes a specific checkable retention commitment, with transcripts automatically deleted after a stated short window, rather than a general assurance.
- The review step is named rather than implied, with a defined feature for checking the draft before it is used.
- It lives inside a clinical information service clinicians already open daily for other reasons, so the scribe sits beside the reference material rather than in a separate application.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Doximity Scribe and Medscape Scribe are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Doximity Scribe | Medscape Scribe |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2010 | 2024 |
| Headquarters | San Francisco, California, United States | Newark, New Jersey, United States |
| Website | doximity.com | medscape.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Doximity Scribe its top capability grade on AI Safety and PHI Stewardship and Commercial Transparency. Set against Medscape Scribe, Doximity Scribe grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and Security Certifications and Trust Center. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Medscape Scribe its top capability grade on Commercial Transparency. Set against Doximity Scribe, Medscape Scribe grades higher on Autonomy and Oversight Model and AI Liability and Recourse. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Doximity Scribe or Medscape Scribe?
On the axes where the AI Health Index separates them, Doximity Scribe grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and Security Certifications and Trust Center, and Medscape Scribe grades higher on Autonomy and Oversight Model and AI Liability and Recourse. Doximity Scribe leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Doximity Scribe and Medscape Scribe differ most?
The widest separation the AI Health Index records between Doximity Scribe and Medscape Scribe is on Model Supply Chain Disclosure, where Doximity Scribe grades C and Medscape Scribe grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Doximity Scribe and Medscape Scribe grade the same?
The AI Health Index grades Doximity Scribe and Medscape Scribe the same on several axes, including AI Centrality, Model and Technology Transparency and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Doximity Scribe and Medscape Scribe not disclosed?
At the last review, at least one of Doximity Scribe and Medscape Scribe published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Neither product integrates with a record system, so in both cases the note comes back to the clinician and stops there, which is the shared limitation that defines this tier. Neither publishes an accuracy figure, evaluation methodology, model card or subgroup and accent performance analysis, and neither publishes a security attestation.
Both are free because a pharmaceutical company is paying somewhere in the business, and a buyer should understand that the audience, not the software, is the product being monetised. For any institutional use, establish business associate coverage in writing, since one vendor states it and the other does not publish terms.